ArticleCerebellum (London, England)2025
VPS13D-Related Disorders: Description of New Variant and Phenotypic Spectrum Based on Age of Onset.
Article in Cerebellum (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The VPS13 family plays a crucial role in mitochondrial stabilization. Biallelic pathogenic variants in VPS13D are classically associated with autosomal recessive ataxia 4 (OMIM #607317), but phenotypic expression is increasingly recognized in diverse presentations such as early-onset movement disorders. We report on two siblings with childhood onset chorea and ataxia. Neuroimaging disclosed bilateral striatal hyperintensities. Whole-exome sequencing identified compound heterozygous likely pathogenic, novel variants in VPS13D: c.2504G > A (p.Trp835*) and c.9107T > C (p.Val3036Ala). To date, 45 cases of VPS13D-related movement disorders have been reported in the literature. Here, we summarize the main clinical findings and compare key features observed in pediatric and adult presentations. Our results indicate that pediatric cases display a distinct phenotype, with some manifestations, such as epilepsy, occurring exclusively in childhood. This study highlights the heterogeneity of VPS13D-related clinical phenotypes. Pediatric presentations appear to follow a more disabling course, with distinct characteristics according to age of onset. Recognition of these features supports the inclusion of VPS13D variants in the differential diagnosis of early-onset chorea, particularly when accompanied by neuroimaging abnormalities and/or associated epilepsy.
Indexed as
Identifiers
41288814What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.